pharma

  1. P

    Sun Pharma - Gleevec ends, now Glumetza

    On Feb 1st, Sun Pharma launched Gleevec generic in the US - and the 180 day exclusivity period garnered something like $400m in revenues and $300m in profits for Sun Pharma. That exclusivity period ended on 1st August - and the market has assumed that Gleevec will no longer contribute to Sun...